Vaccine marker Biological E is likely to submit final data of its Corebevax Covid-19 vaccine to the DGCI by the end of November, health ministry sources said on Thursday.
Biological E seeks DCGI s nod for phase-3 trial of Corbevax as booster dose for Covishield, Covaxin indiatoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatoday.in Daily Mail and Mail on Sunday newspapers.
Currently, phase 2/3 clinical trials of the second indigenously developed Corbevax, to be administered in adults aged 18 years to 80 years, is underway and the results are likely to be declared this month.
Biological E has sought permission from India's drug regulator to conduct the phase-3 clinical trial for its COVID-19 vaccine Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin.
Biological E s COVID-19 vaccine Corbevax likely in October: Dr VK Paul businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.